Amy S. Broidrick Qualigen Therapeutics, Inc. (QLGN) insider trading activity
Amy S. Broidrick is President/CSO of Qualigen Therapeutics, Inc.. Currently has a direct ownership of 34,500 shares of QLGN, which is worth approximately $135,585. The most recent transaction as insider was on Jun 14, 2022, when has been sold 30,000 shares (Common Stock) at a price of $0.62 per share, resulting in proceeds of $18,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
34.5K
0%
3M change
0%
12M change
Total Value Held
$135,585
AMY S. BROIDRICK Transaction History
ASB
Amy S. Broidrick
President/CSO
Carlsbad, CA